By WSJ Staff
Novo Nordisk (NVO): The Food and Drug Administration approved Novo Nordisk's popular weight-loss drug Wegovy to treat a form of liver disease. Shares climbed roughly 4.5% in Denmark (read more about weight-loss drugs' surprise foe).
Soho House $(SHCO)$: Investors led by one of the U.S.'s biggest hotel owners are nearing a deal to take Soho House private, The Wall Street Journal reported. Shares in the members' club operator rose 13% in premarket trading.
UnitedHealth $(UNH)$: Shares gained 3% premarket, after leaping Friday following Berkshire Hathaway $(BRK.B)$'s disclosure that it had taken a stake in the embattled health insurer.
Grand Canyon Education $(LOPE)$: The Federal Trade Commission dismissed a Biden-era complaint that accused the education company of falsely claiming to be a nonprofit.
Palo Alto Networks (PANW): The cybersecurity company is set to publish quarterly results after the market close. It recently agreed to buy CyberArk Software $(CYBR)$ for $25 billion.
This item is part of a Wall Street Journal live coverage event. The full stream can be found by searching P/WSJL (WSJ Live Coverage).
(END) Dow Jones Newswires
August 18, 2025 05:23 ET (09:23 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.